Stock Ticker

  • Loading stock data...

Announcement Of Showcasing AutoloGel System At Advanced Wound Care Symposium Fails To Stop Slide At Cytomedix (CMXI)

The failure to clinch a licensing contract for the flagship product AutoloGel from a top-20 global pharmaceutical company continues to haunt the fully integrated regenerative medicine company Cytomedix (OTC: CMXI). The company’s share price continued its downward spiral by another 9% amidst high volume. Cytomedix, the developer of platelet and adult stem cell technologies for […]

Cytomedix Share Price Surges After Coverage Determination Granted by CMS (CMXI)

Cytomedix (OTC: CMXI) staged a huge rally in today’s trading session after informing the public that the Center for Medicare & Medicaid Services (CMS) granted Coverage with Evidence Development (CED) for the Cytomedix AutoloGel products. Today’s press release mentions that the Centers for Medicare & Medicaid Services issued a National Coverage Determination (NCD) on August 2, […]

Medicare Coverage Heals A Painful Summer For Cytomedix (CMXI)

A dismal summer for Cytomedix (OTC: CMXI) stock suddenly turned a little brighter today. The Centers for Medicare and Medicaid Services announced that they had approved coverage for autologous blood-derived products (the patient’s own blood) used in the treatment of chronic wounds specifically resulting from diabetes and pressure or venous wounds. Cytomedix develops and sells regenerative therapies including […]

Sign Up To Get Our Latest Stocks Alerts